Praxis Precision Medicines Inc (NASDAQ:PRAX) shares, rose in value on Thursday, April 16, with the stock price up by 13.29% to the previous day’s close as strong demand from buyers drove the stock to $33.79.
Actively observing the price movement in the last trading, the stock closed the session at $29.83, falling within a range of $29.47 and $33.9. The value of beta (5-year monthly) was 2.676. Referring to stock’s 52-week performance, its high was $91.83, and the low was $26.70. On the whole, PRAX has fluctuated by -12.51% over the past month.
With the market capitalization of Praxis Precision Medicines Inc currently standing at about $681.32 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-27.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 183.1k.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PRAX’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of PRAX currently trading nearly 0.06% and -30.33% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 43.74, while the 7-day volatility ratio is showing 7.23% which for the 30-day chart, stands at 9.08%. Furthermore, Praxis Precision Medicines Inc (PRAX)’s beta value is 2.69, and its average true range (ATR) is 3.27.
A comparison of Praxis Precision Medicines Inc (PRAX) with its peers suggests the former has fared considerably weaker in the market. PRAX showed an intraday change of 13.29% in last session, and over the past year, it shrunk by -35.53%%.
Data on historical trading for Praxis Precision Medicines Inc (NASDAQ:PRAX) indicates that the trading volumes over the past 10 days have averaged 0.64 and over the past 3 months, they’ve averaged 542.65K. According to company’s latest data on outstanding shares, there are 19.42 million shares outstanding.
Nearly 7.07% of Praxis Precision Medicines Inc’s shares belong to company insiders and institutional investors own 105.53% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.99 million shares as on 2025-03-31, resulting in a short ratio of 2.95. According to the data, the short interest in Praxis Precision Medicines Inc (PRAX) stood at 987.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 1.82 million. The stock has fallen by -56.09% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PRAX stock heading into the next quarter.
